Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing total funding to over $25M. This funding will accelerate the development of it…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=1002728&sourceType=rss [/auto_ads_show_after_click]